MT1-MMP–dependent neovessel formation within the confines of the three-dimensional extracellular matrix

During angiogenesis, endothelial cells initiate a tissue-invasive program within an interstitial matrix comprised largely of type I collagen. Extracellular matrix–degradative enzymes, including the matrix metalloproteinases (MMPs) MMP-2 and MMP-9, are thought to play key roles in angiogenesis by binding to docking sites on the cell surface after activation by plasmin- and/or membrane-type (MT) 1-MMP–dependent processes. To identify proteinases critical to neovessel formation, an ex vivo model of angiogenesis has been established wherein tissue explants from gene-targeted mice are embedded within a three-dimensional, type I collagen matrix. Unexpectedly, neither MMP-2, MMP-9, their cognate cell-surface receptors (i.e., β3 integrin and CD44), nor plasminogen are essential for collagenolytic activity, endothelial cell invasion, or neovessel formation. Instead, the membrane-anchored MMP, MT1-MMP, confers endothelial cells with the ability to express invasive and tubulogenic activity in a collagen-rich milieu, in vitro or in vivo, where it plays an indispensable role in driving neovessel formation.

[1]  S. Maxwell,et al.  Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. , 2001, Journal of cell science.

[2]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[3]  P. Ward,et al.  Heterogeneity of vascular endothelial cells: differences in susceptibility to neutrophil-mediated injury. , 1998, Microvascular research.

[4]  S. Weiss,et al.  Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. , 2000, Molecular biology of the cell.

[5]  J A Kiernan,et al.  Layered structure of saccular aneurysms assessed by collagen birefringence. , 1999, Neurological research.

[6]  Stephen J. Weiss,et al.  Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.

[7]  I. Stamenkovic,et al.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.

[8]  S. Itohara,et al.  Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.

[9]  R. Nicosia,et al.  The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. , 1987, The American journal of pathology.

[10]  D. Boger,et al.  Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Itohara,et al.  Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. , 2003, Investigative ophthalmology & visual science.

[12]  K. Akassoglou,et al.  Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. , 2001, American journal of physiology. Heart and circulatory physiology.

[13]  P. Quax,et al.  Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. , 2003, Blood.

[14]  Timo Sorsa,et al.  Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.

[15]  S. Itohara,et al.  Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice , 2004, Oncogene.

[16]  María Yáñez-Mó,et al.  ECM regulates MT1-MMP localization with β1 or αvβ3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells , 2002, The Journal of cell biology.

[17]  H. Mori,et al.  CD44 directs membrane‐type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin‐like domain , 2002, The EMBO journal.

[18]  M. H. Hardy,et al.  The differentiation of the dermis in the laboratory mouse. , 1984, The American journal of anatomy.

[19]  Z. Werb,et al.  Expression of gelatinase A, a mediator of extracellular matrix remodeling, by tracheal gland serous cells in culture and in vivo. , 1994, The Journal of biological chemistry.

[20]  T. Betsuyaku,et al.  Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. , 2000, The American journal of pathology.

[21]  A. Saven,et al.  Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Z. Werb,et al.  Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. , 2002, Journal of cell science.

[23]  D. Edwards,et al.  Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). , 2002, Journal of cell science.

[24]  Koichi Hattori,et al.  Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases , 2003, Current opinion in hematology.

[25]  Jingsong Xu,et al.  Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo , 2001, The Journal of cell biology.

[26]  Motoharu Seiki,et al.  The cell surface: the stage for matrix metalloproteinase regulation of migration. , 2002, Current opinion in cell biology.

[27]  R. Poorman,et al.  Interstitial collagenase is required for angiogenesis in vitro. , 1994, Developmental biology.

[28]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[29]  P. Wingfield,et al.  TIMP-2 Mediated Inhibition of Angiogenesis An MMP-Independent Mechanism , 2003, Cell.

[30]  R. Hynes,et al.  Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.

[31]  R. Nicosia,et al.  Regulation of Vascular Growth and Regression by Matrix Metalloproteinases in the Rat Aorta Model of Angiogenesis , 2000, Laboratory Investigation.

[32]  J. Mulé,et al.  Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. , 2001, The Journal of clinical investigation.

[33]  H. Mori,et al.  Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.

[34]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[35]  Jeffrey W. Smith,et al.  Functional activation of integrin αvβ3 in tumor cells expressing membrane‐type 1 matrix metalloproteinase , 2000 .

[36]  P. Noble,et al.  CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. , 2002, The American journal of pathology.

[37]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[38]  E. Hay,et al.  Cell Biology of Extracellular Matrix , 1988, Springer US.

[39]  J. Quigley,et al.  Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. , 2001, Blood.

[40]  L. Lund,et al.  Impaired wound healing in mice with a disrupted plasminogen gene , 1996, Nature Medicine.

[41]  M. Pepper.  Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[42]  D. Taverna,et al.  Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins , 2002, Nature Medicine.

[43]  W. Stetler-Stevenson,et al.  Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. , 2003, The American journal of pathology.

[44]  T. Haas,et al.  Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. , 1998, The Journal of biological chemistry.

[45]  Tadej Battelino,et al.  TGF-β Plays a Key Role in Morphogenesis of the Pancreatic Islets of Langerhans by Controlling the Activity of the Matrix Metalloproteinase MMP-2 , 1998, The Journal of cell biology.

[46]  D. Cheresh,et al.  Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity , 1998, Cell.

[47]  Y. Okada,et al.  Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.

[48]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[49]  Kayla J Bayless,et al.  Molecular basis of endothelial cell morphogenesis in three‐dimensional extracellular matrices , 2002, The Anatomical record.

[50]  T. Borg,et al.  Expression and accumulation of interstitial collagen in the neonatal rat heart , 1993, The Anatomical record.

[51]  S. Weiss,et al.  Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent Processes , 2002, The Journal of experimental medicine.

[52]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[53]  M. Krasnow,et al.  Tube Morphogenesis Making and Shaping Biological Tubes , 2003, Cell.

[54]  Mina J. Bissell,et al.  Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis , 2003, The Journal of cell biology.

[55]  L. Coussens,et al.  Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[56]  P. Libby,et al.  Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth , 2003, Circulation research.

[57]  M. Bernardo,et al.  Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. , 2003, Biochemical and biophysical research communications.

[58]  G. Murphy,et al.  Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model , 2001, FEBS letters.

[59]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[60]  L. Creemers,et al.  Microassay for the assessment of low levels of hydroxyproline. , 1997, BioTechniques.

[61]  I. Macdonald,et al.  Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. , 2000, Cancer research.

[62]  Thiennu H. Vu,et al.  Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.

[63]  R. W. Rauser,et al.  Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[64]  W. Gerald,et al.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.